Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Temperature regulation suppression: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>David Hedlund
===External links=== * [https://en.wikipedia.org/wiki/Thermoregulation_in_humans Thermoregulation in humans (Wikipedia)]
>Graham
Reference
Line 1: Line 1:
<onlyinclude>
<onlyinclude>
'''Temperature regulation suppression''' can be defined as an inability to maintain a normal temperature. This results in feelings of constantly fluctuating between being uncomfortably cold and uncomfortably hot. It varies in its intensity between different substances but is particularly common within stimulating compounds.
'''Temperature regulation suppression''' can be defined as an inability to maintain a normal temperature. This results in feelings of constantly fluctuating between being uncomfortably cold<ref>Walsh, S. L., Strain, E. C., Abreu, M. E., & Bigelow, G. E. (2001). Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology, 157(2), 151-162. https://doi.org/10.1007/s002130100788</ref> and uncomfortably hot. It varies in its intensity between different substances but is particularly common within stimulating compounds.
</onlyinclude>
</onlyinclude>
===Psychoactive substances===
===Psychoactive substances===

Revision as of 20:12, 2 March 2018

Temperature regulation suppression can be defined as an inability to maintain a normal temperature. This results in feelings of constantly fluctuating between being uncomfortably cold[1] and uncomfortably hot. It varies in its intensity between different substances but is particularly common within stimulating compounds.

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Anecdotal reports which describe this effect within our experience index include:

See also

  1. Walsh, S. L., Strain, E. C., Abreu, M. E., & Bigelow, G. E. (2001). Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology, 157(2), 151-162. https://doi.org/10.1007/s002130100788